000			02105 a2200625 4500
005			20250518033547.0
264		0	_c20190610
008			201906s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2019.01.057 _2doi
040			_aNLM _beng _cNLM
100	1		_aBaek, C H
245	0	0	_aRandomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids. _h[electronic resource]
260			_bTransplantation proceedings _cApr 2019
300			_a749-760 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdrenal Cortex Hormones _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aDelayed-Action Preparations _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate
650	0	4	_aGraft Rejection _xprevention & control
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aKidney Transplantation
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPatient Satisfaction
650	0	4	_aRepublic of Korea
650	0	4	_aResearch Design
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTransplant Recipients
700	1		_aKim, C-D
700	1		_aLee, D R
700	1		_aKim, Y H
700	1		_aYang, J
700	1		_aKim, B S
700	1		_aLee, J S
700	1		_aHan, S Y
700	1		_aKim, S W
700	1		_aLee, S
700	1		_aLee, K W
700	1		_aKong, J M
700	1		_aShin, B C
700	1		_aLee, S H
700	1		_aChae, D W
700	1		_aKwon, Y J
700	1		_aJiang, H
700	1		_aLee, H
700	1		_aPark, S-K
773	0		_tTransplantation proceedings _gvol. 51 _gno. 3 _gp. 749-760
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2019.01.057 _zAvailable from publisher's website
999			_c29583184 _d29583184